Penumbra Begins FORWARD Study of Red Perfusion Catheter Portfolio in Distal Acute Ischemic Stroke Management

First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke

ALAMEDA, Calif., July 7, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and efficacy data on mechanical…

First patient enrolled in Penumbra's FORWARD study of mechanical thrombectomy for distal acute ischaemic stroke

Penumbra has announced the initiation of its FORWARD study, an international, real-world prospective, multicentre study. The study will collect safety and efficacy data on mechanical thrombectomy, including computer assisted vacuum thrombectomy (CAVT) and modulated aspiration, in the management of acute ischaemic stroke with distal occlusions. The first patient was treated by Keith Woodward, neurointerventional radiologist at Vista Radiology in …

Penumbra Begins FORWARD Study of Red Perfusion Catheter Portfolio in Distal Acute Ischemic Stroke Management

July 7, 2026—Penumbra, Inc. announced the initiation of its FORWARD study, which will collect safety and efficacy data on mechanical thrombectomy in the management of acute ischemic stroke with distal occlusions. The first patient in the study was treated by Keith Woodward, MD, neurointerventional radiologist at Vista Radiology in Knoxville, Tennessee. According to Penumbra, FORWARD is an international, multicenter, prospective study of function…